@lancetgastrohep.bsky.social
The Lancet Gastroenterology & Hepatology is the world-leading #gastroenterology and #hepatology research journal. IF=39.1.
@thelancet.comReposted by @lancetgastrohep.bsky.social🆕 Out now: The Lancet Regional Health – Eastern Mediterranean’s inaugural issue. #goldopenaccess
“The scale of the challenges the region has faced this past year can be hard to absorb. It is in this context that this journal takes shape.”
Explore the new issue: spkl.io/633277VQx7
@lancetgastrohep.bsky.socialOur November 2026 issue is out now - visit www.thelancet.com/gastrohep!
Content includes: #IBD, #MASH, #livercancer, #colorectalcancer, #cirrhosis, #IBS + more...
@lancetgastrohep.bsky.socialNew research - Short-course prophylaxis with the Toronto HCV protocol for recipients of non-liver solid organ transplants from donors with hepatitis C viraemia: a retrospective, matched cohort study
@lancetgastrohep.bsky.socialNew @thelancet.com - Faecal microbiota transplantation in irritable bowel syndrome (REFIT2): a randomised, double-blind, placebo-controlled, phase 3 trial
@thelancetoncol.bsky.socialReposted by @lancetgastrohep.bsky.socialJust launched: Accelerating equitable cancer genomics and precision oncology in health care and research: a
@thelancetoncol.bsky.social Commission
With a new framework, implementation could be more equitable, effective, and sustainable
Read more: thelancet.com/commissions-...
@thelancet.comReposted by @lancetgastrohep.bsky.socialEarly-onset colorectal cancer (EO-CRC) is increasing globally.
In The Lancet Regional Health - Eastern Mediterranean, authors assessed the burden, temporal trends, and future projections of EO-CRC across the WHO Eastern Mediterranean Region: spkl.io/633217TcwT
@lancetgastrohep.bsky.socialThe burden of early-onset colorectal cancer in the WHO Eastern Mediterranean Region: an analysis of GLOBOCAN 2022 data
🆕 at The Lancet Regional Health - Eastern Mediterranean!
@thelancetrheum.bsky.socialReposted by @lancetgastrohep.bsky.socialOur Oct 2026 issue is live!
Including research on #musculoskeletal #ultrasound and #lupus #arthritis, plus much more! thelancet.com/journals/lan...
@eclinicalmed.bsky.socialReposted by @lancetgastrohep.bsky.social📢NEW: September issue now online featuring #NoonanSyndrome, #Stroke, #HIV, #Spondyloarthritis, #Diabetes, #Sepsis, #Asthma, and more with our editorial on the rise of early-onset cancer
…all available #free, #OpenAccess❗️
Read more here: www.thelancet.com/issue/S2589-...
Attribution: Getty
@thelancetoncol.bsky.socialReposted by @lancetgastrohep.bsky.social🔴Online now: Global health expenditures on cancer control: a cross-sectional analysis
"By making cancer expenditures visible and comparable, this work helps create an evidence base to inform priority setting and allocation decisions for cancer control."
@lancetrh-europe.bsky.socialReposted by @lancetgastrohep.bsky.socialThe landscape of hepatocellular carcinoma in Europe is changing.
Chaired by Prof David Pinato, the Series examines the evolving #HCC burden, persistent surveillance gaps, advances in treatment and inequalities in access to care.
Read more 👇
shorturl.at/qo8g1
@lancetgastrohep.bsky.socialNew research - Aspirin after curative-intent treatment of colorectal cancer liver metastases (ASAC): a multicentre, phase 3, randomised, double-blind, placebo-controlled trial
@lancetgastrohep.bsky.socialResearch - Prevalence of liver fibrosis and steatotic liver disease in community-dwelling adults in China (the CHESS-LiverHealth project): cross-sectional baseline data from a prospective cohort study
@lancetgastrohep.bsky.socialNew Research - Genetic variants and the risk of renal impairment in decompensated cirrhosis: a multi-ancestry genome-wide association study
@lancetgastrohep.bsky.social🆕Long-term outcomes of top-down therapy versus a conventional step-up strategy in adults newly diagnosed with Crohn's disease: 5-year follow-up of the PROFILE trial
@lancetgastrohep.bsky.social🆕Germline multigene panel testing for colorectal cancer: a systematic review and meta-analysis
@lancetgastrohep.bsky.socialThe Oct 2026 issue of @LancetGastroHep is out today! www.thelancet.com/gastrohep
Content includes: #colorectalcancer, #MASLD, #viralhepatitis, #DGBI, #LynchSyndrome, bowel #endometriosis + more!
@lancetrh-wpac.bsky.socialReposted by @lancetgastrohep.bsky.socialOur new issue is live!🙌
Check out papers about new point-of-care diagnosis triage for #COPD, climate hazard and #MentalHealth hospitalisations, #UlcerativeColitis sub-phenotyping, and long-term #cancer prevalence projection in #Australia... & more!
@lancetimaging.bsky.socialReposted by @lancetgastrohep.bsky.social📢 We’ve published our first issue!
Read and download our inaugural issue here ➡️ www.thelancet.com/issue/S3117-...
Thank you to our authors and reviewers for their valuable contributions ✨
As a gold open access journal, our content is free to read by everyone, always. #OA
@lancetgastrohep.bsky.socialNew research - ALG-055009 in non-cirrhotic adults with metabolic dysfunction-associated steatohepatitis (HERALD): a randomised, double-blind, placebo-controlled, phase 2a trial
